The biopharmaceutical company’s drug in development is designed to treat gastrointestinal stromal tumors (GIST). Read More
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!